Annual General Meeting 2024

Tecan shareholders endorse all motions proposed by the Board of Directors - Seite 2

Various amendments to the Articles of Incorporation approved
Shareholders approved a number of amendments to the Articles of Incorporation. These are intended to adapt the Articles of Incorporation to the revised corporate law and take account of current best practices in the area of corporate governance. The Articles of Incorporation now allow future General Meetings to be held virtually if necessary. To ensure a broad range of skills and appropriate diversity on the Tecan Board of Directors, the maximum number of Board members was increased from seven to eight. Tecan has also expanded the definition of its corporate purpose in order to anchor the pursuit of sustainable value creation in the Articles of Incorporation.

Other proposals also approved
The shareholders voted on the conditions governing the compensation of the Board of Directors and Management Board for the following fiscal year. They made a binding decision to endorse the proposed maximum total amount of compensation for fiscal year 2025 and also, for the Board of Directors, for the period until the 2025 Annual General Meeting. The 2023 Compensation Report, which was submitted for an advisory vote, was also accepted by shareholders.
For the first time, Tecan submitted a report on non-financial matters for 2023 to the Annual General Meeting for approval. The company is thus fulfilling a new legal requirement and increasing the transparency and commitment of its sustainability reporting. This report was also approved by the shareholders.

Ernst & Young AG, Zurich, was reappointed as the statutory auditors for fiscal year 2024.
Shareholders approved the motion proposed by the Board of Directors to appoint Proxy Voting Services GmbH, Zurich, as the independent proxy for the period up to the close of the Tecan Group 39^th Annual General Meeting in 2025.

Key upcoming dates

• The 2024 Interim Report will be published on August 13, 2024.
• The Capital Markets Day will take place on October 22, 2024.

About Tecan
Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,500 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2023, Tecan generated sales of CHF 1,074 million (USD 1,194 million; EUR 1,108 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:
Tecan Group
Martin Braendle
Senior Vice President, Corporate Communications & IR
Tel. [phone]
Fax [phone]
[e-mail]
www.tecan.com

Attachment

• Press Release